These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 8251904

  • 1. The biology of normal and neoplastic stem cells in CML.
    Eaves C, Udomsakdi C, Cashman J, Barnett M, Eaves A.
    Leuk Lymphoma; 1993; 11 Suppl 1():245-53. PubMed ID: 8251904
    [Abstract] [Full Text] [Related]

  • 2. MCP-1, not MIP-1alpha, is the endogenous chemokine that cooperates with TGF-beta to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures.
    Cashman JD, Eaves CJ, Sarris AH, Eaves AC.
    Blood; 1998 Oct 01; 92(7):2338-44. PubMed ID: 9746772
    [Abstract] [Full Text] [Related]

  • 3. Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.
    Holyoake TL, Freshney MG, Sproul AM, Richmond LJ, Alcorn MJ, Steward WP, Fitzsimons E, Dunlop DJ, Franklin IM, Pragnell IB.
    Stem Cells; 1993 Oct 01; 11 Suppl 3():122-8. PubMed ID: 8298472
    [Abstract] [Full Text] [Related]

  • 4. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level.
    Udomsakdi C, Eaves CJ, Swolin B, Reid DS, Barnett MJ, Eaves AC.
    Proc Natl Acad Sci U S A; 1992 Jul 01; 89(13):6192-6. PubMed ID: 1631107
    [Abstract] [Full Text] [Related]

  • 5. Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.
    Carlo-Stella C, Dotti G, Mangoni L, Regazzi E, Garau D, Bonati A, Almici C, Sammarelli G, Savoldo B, Rizzo MT, Rizzoli V.
    Blood; 1996 Oct 15; 88(8):3091-100. PubMed ID: 8874208
    [Abstract] [Full Text] [Related]

  • 6. Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells.
    Eaves CJ, Cashman JD, Wolpe SD, Eaves AC.
    Proc Natl Acad Sci U S A; 1993 Dec 15; 90(24):12015-9. PubMed ID: 8265663
    [Abstract] [Full Text] [Related]

  • 7. The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: evidence for an indirect mechanism.
    Cashman JD, Eaves AC, Eaves CJ.
    Blood; 1994 Sep 01; 84(5):1534-42. PubMed ID: 8068944
    [Abstract] [Full Text] [Related]

  • 8. Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-beta on normal and leukemic human hematopoietic progenitor cells.
    Cashman JD, Eaves AC, Eaves CJ.
    Leukemia; 1992 Sep 01; 6(9):886-92. PubMed ID: 1518302
    [Abstract] [Full Text] [Related]

  • 9. Phenotypic heterogeneity of primitive leukemic hematopoietic cells in patients with chronic myeloid leukemia.
    Udomsakdi C, Eaves CJ, Lansdorp PM, Eaves AC.
    Blood; 1992 Nov 15; 80(10):2522-30. PubMed ID: 1384787
    [Abstract] [Full Text] [Related]

  • 10. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
    Veena P, Cornetta K, Davidson A, Agüero B, McMahel J, Traycoff CM, Srour EF.
    Bone Marrow Transplant; 1997 Jun 15; 19(12):1213-21. PubMed ID: 9208115
    [Abstract] [Full Text] [Related]

  • 11. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.
    Verfaillie CM, Bhatia R, Miller W, Mortari F, Roy V, Burger S, McCullough J, Stieglbauer K, Dewald G, Heimfeld S, Miller JS, McGlave PB.
    Blood; 1996 Jun 01; 87(11):4770-9. PubMed ID: 8639848
    [Abstract] [Full Text] [Related]

  • 12. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages.
    Bhatia R, McGlave PB, Dewald GW, Blazar BR, Verfaillie CM.
    Blood; 1995 Jun 15; 85(12):3636-45. PubMed ID: 7780147
    [Abstract] [Full Text] [Related]

  • 13. Differential manipulation of normal and chronic myeloid leukemia stem cell proliferation in vitro.
    Eaves C, Eaves A.
    Blood Cells; 1994 Jun 15; 20(1):83-93; discussion 93-5. PubMed ID: 7994064
    [Abstract] [Full Text] [Related]

  • 14. Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML).
    Gentil M, Hugues P, Desterke C, Telliam G, Sloma I, Souza LEB, Baykal S, Artus J, Griscelli F, Guerci A, Johnson-Ansah H, Foudi A, Bennaceur-Griscelli A, Turhan AG.
    PLoS One; 2018 Jun 15; 13(8):e0200923. PubMed ID: 30091999
    [Abstract] [Full Text] [Related]

  • 15. Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation.
    Bhatia R, Munthe HA, Williams AD, Zhang F, Forman SJ, Slovak ML.
    Exp Hematol; 2000 Dec 15; 28(12):1401-12. PubMed ID: 11146162
    [Abstract] [Full Text] [Related]

  • 16. Stem cell factor and chronic myeloid leukemia CD34+ cells.
    Moore S, McDiarmid LA, Hughes TP.
    Leuk Lymphoma; 2000 Jul 15; 38(3-4):211-20. PubMed ID: 10830729
    [Abstract] [Full Text] [Related]

  • 17. Stem cell factor as a single agent induces selective proliferation of the Philadelphia chromosome positive fraction of chronic myeloid leukemia CD34(+) cells.
    Moore S, Haylock DN, Lévesque JP, McDiarmid LA, Samels LM, To LB, Simmons PJ, Hughes TP.
    Blood; 1998 Oct 01; 92(7):2461-70. PubMed ID: 9746786
    [Abstract] [Full Text] [Related]

  • 18. Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells.
    Otsuka T, Eaves CJ, Humphries RK, Hogge DE, Eaves AC.
    Leukemia; 1991 Oct 01; 5(10):861-8. PubMed ID: 1961020
    [Abstract] [Full Text] [Related]

  • 19. Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia.
    Petzer AL, Eaves CJ, Lansdorp PM, Ponchio L, Barnett MJ, Eaves AC.
    Blood; 1996 Sep 15; 88(6):2162-71. PubMed ID: 8822936
    [Abstract] [Full Text] [Related]

  • 20. Regulatory activity of endogenous MIP-1 alpha in long-term cultures of human marrow.
    Cashman JD, Eaves AC, Wolpe S, Eaves CJ.
    Prog Clin Biol Res; 1994 Sep 15; 389():261-8. PubMed ID: 7700910
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.